Fundz

Evariste

London, England, United Kingdom · Biotechnology, Health Care, Manufacturing

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain.

Key facts

Headquarters
London, England, United Kingdom
Employees
15
Industries
Biotechnology, Health Care, Manufacturing
Status
Private
Website
www.evariste.com
LinkedIn
Company page

Recent activity at Evariste

Leadership

  • Alfie Brennan, Chief Technology Officer
  • Tracy Mak, Chief Operating Officer
  • Evariste Pecqueur, Chief Financial Officer
  • Évariste Yaméni, Chief Executive Officer
  • Evariste Agui, Responsable Des Rh
  • Evariste Djo Kabwe, Human Resources Specialist
  • Evariste Verchere, Head of Public Debt Portfolio Management
  • Evariste Logota, Senior Network Engineer
  • Evariste Bango Yankom-Honde, Senior Information Technology Support Engineer
  • Evariste Abanda, Territory Sales Coordinator
  • Evariste Dabire, Sales Trainer

Verified email and direct lines for Evariste’s decision-makers are on Fundz. See plans

Evariste in the news

Companies similar to Evariste

About Evariste: questions and answers

What does Evariste do?

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain.

Where is Evariste headquartered?

Evariste is headquartered in London, England, United Kingdom.

How many employees does Evariste have?

Evariste has about 15 employees.

Who leads Evariste?

Évariste Yaméni is a Chief Executive Officer at Evariste.

What is the latest news on Evariste?

On Jan 13, 2025, Evariste Partners With University of Southampton to Generate Oesophageal Adenocarcinoma Dataset

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Evariste across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.